{
    "nctId": "NCT01043913",
    "briefTitle": "Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue",
    "officialTitle": "Guaran\u00e1 (\"Paullinia Cupana\") for Chemotherapy Related Fatigue in Breast Cancer Patients: Results Of A Pilot Double Blind Randomized Study",
    "overallStatus": "COMPLETED",
    "conditions": "Signs and Symptoms, Neoplasms, Neoplasms by Site, Fatigue, Breast Neoplasms, Breast Diseases",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Fatigue improvement between the baseline to D21 or from D21 to D42 measured by Chalder Fatigue Scale, FACT-F and FACT-ES questionnaires",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histological diagnosis of Breast Cancer\n* Patients undergoing Chemotherapy (First Cycle)\n* 18 years old or older\n\nExclusion Criteria:\n\n* Hypothyroidism\n* Clinical Depression\n* Prior Chemotherapy\n* Anemia\n* Unable to sign informed consent\n* Severe Fatigue",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}